 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
SUMMARIES FOR PATIENTS
Identifying People at High Risk for Type 2 Diabetes
16 April 2002 | Volume 136 Issue 8 | Page I29
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine.
The summary below is from the full report titled "Identification of Persons at High Risk for Type 2 Diabetes Mellitus: Do We Need the Oral Glucose Tolerance Test?" It is in the 16 April 2002 issue of Annals of Internal Medicine (volume 136, pages 575-581). The authors are MP Stern, K Williams, and SM Haffner.
What is the problem and what is known about it so far?
Type 2 diabetes mellitus, also known as adult-onset diabetes, is a common disease that interferes with the body's ability to use sugar, resulting in high levels in the blood. Over time, high blood sugar levels can lead to complications such as blindness, kidney failure, and heart disease. Diet, exercise, or medications can prevent people who are at high risk for type 2 diabetes from developing the disease. The standard way of identifying people at risk for type 2 diabetes is to measure blood sugar levels 2 hours after a standard amount of sugar is consumed. This test is called an oral glucose tolerance test, and it is inconvenient and costly. Easier and less costly ways of identifying people who might benefit from strategies to prevent diabetes would be useful.
Why did the researchers do this particular study?
To see whether a mathematical model that uses readily available medical information can predict who is likely to develop diabetes as accurately as an oral glucose tolerance test does.
Who was studied?
1791 Mexican Americans and 1112 non-Hispanic white people who did not have diabetes when they were enrolled in the study.
How was the study done?
The researchers collected information about each patient's medical history, blood pressure, body size, cholesterol levels, and sugar levels (during fasting and during an oral glucose tolerance test). They followed the participants to see who developed diabetes over the next 7.5 years. Then, the researchers developed three mathematical models. The first model used only oral glucose tolerance test results. The second model used only the other medical information (clinical model). The third model used both the oral glucose tolerance test results and the medical information.
What did the researchers find?
The model that used only the medical information was much better at predicting who would develop diabetes than the model that used only the oral glucose tolerance results. Adding the oral glucose tolerance test results to the clinical model improved prediction only slightly.
What were the limitations of the study?
This study included many Mexican Americans, who have a higher risk for type 2 diabetes than many other ethnic groups. Before such a model could be used widely, similar results would need to be demonstrated in more diverse sets of people. In addition, the mathematical models would need to be translated for use on doctors' own computers.
What are the implications of the study?
A mathematical model that uses readily available medical information may prove to be a good way to identify patients at risk for type 2 diabetes while avoiding the cost and inconvenience of oral glucose tolerance tests.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  M. A. Abdul-Ghani, T. Abdul-Ghani, N. Ali, and R. A. DeFronzo One-Hour Plasma Glucose Concentration and the Metabolic Syndrome Identify Subjects at High Risk for Future Type 2 Diabetes Diabetes Care, August 1, 2008; 31(8): 1650 - 1655. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Stern, K. Williams, D. Eddy, and R. Kahn Validation of Prediction of Diabetes by the Archimedes Model and Comparison With Other Predicting Models Diabetes Care, August 1, 2008; 31(8): 1670 - 1671. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Norris, D. Kansagara, C. Bougatsos, and R. Fu Screening Adults for Type 2 Diabetes: A Review of the Evidence for the U.S. Preventive Services Task Force Ann Intern Med, June 3, 2008; 148(11): 855 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rahman, R. K Simmons, A.-H. Harding, N. J Wareham, and S. J Griffin A simple risk score identifies individuals at high risk of developing Type 2 diabetes: a prospective cohort study Fam. Pract., June 1, 2008; 25(3): 191 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Heikes, D. M. Eddy, B. Arondekar, and L. Schlessinger Diabetes Risk Calculator: A simple tool for detecting undiagnosed diabetes and pre-diabetes Diabetes Care, May 1, 2008; 31(5): 1040 - 1045. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Seidel, R. O. Powell, J. C. Zgibor, L. M. Siminerio, and G. A. Piatt Translating the Diabetes Prevention Program Into an Urban Medically Underserved Community: A nonrandomized prospective intervention study Diabetes Care, April 1, 2008; 31(4): 684 - 689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Rosal, E. M. Benjamin, P. S. Pekow, S. C. Lemon, and D. von Goeler Opportunities and Challenges for Diabetes Prevention at Two Community Health Centers Diabetes Care, February 1, 2008; 31(2): 247 - 254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Schooling, C. Jiang, T. H. Lam, G. N. Thomas, M. Heys, Bmbs, X. Lao, W. Zhang, P. Adab, K. K. Cheng, et al. Height, Its Components, and Cardiovascular Risk Among Older Chinese: A Cross-Sectional Analysis of the Guangzhou Biobank Cohort Study Am J Public Health, October 1, 2007; 97(10): 1834 - 1841. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Valdez, K. J. Greenlund, M. J. Khoury, and P. W. Yoon Is Family History a Useful Tool for Detecting Children at Risk for Diabetes and Cardiovascular Diseases? A Public Health Perspective Pediatrics, September 1, 2007; 120(SUPPLEMENT_2): S78 - S86. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Abdul-Ghani, K. Williams, R. A. DeFronzo, and M. Stern What Is the Best Predictor of Future Type 2 Diabetes? Diabetes Care, June 1, 2007; 30(6): 1544 - 1548. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. W. F. Wilson, J. B. Meigs, L. Sullivan, C. S. Fox, D. M. Nathan, and R. B. D'Agostino Sr Prediction of Incident Diabetes Mellitus in Middle-aged Adults: The Framingham Offspring Study Arch Intern Med, May 28, 2007; 167(10): 1068 - 1074. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. De Hert, L. Hanssens, R. van Winkel, M. Wampers, D. Van Eyck, A. Scheen, and J. Peuskens A Case Series: Evaluation of the Metabolic Safety of Aripiprazole Schizophr Bull, May 1, 2007; 33(3): 823 - 830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Schulze, K. Hoffmann, H. Boeing, J. Linseisen, S. Rohrmann, M. Mohlig, A. F.H. Pfeiffer, J. Spranger, C. Thamer, H.-U. Haring, et al. An Accurate Risk Score Based on Anthropometric, Dietary, and Lifestyle Factors to Predict the Development of Type 2 Diabetes Diabetes Care, March 1, 2007; 30(3): 510 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Nathan, M. B. Davidson, R. A. DeFronzo, R. J. Heine, R. R. Henry, R. Pratley, and B. Zinman Impaired Fasting Glucose and Impaired Glucose Tolerance: Implications for care Diabetes Care, March 1, 2007; 30(3): 753 - 759. [Full Text] [PDF]
|
|
|
|
|
|
M. B. Davidson Clinical Implications of the DREAM Study Diabetes Care, February 1, 2007; 30(2): 418 - 420. [Full Text] [PDF]
|
|
|
|
|
|
O. Cohen, R. Basu, G. Bock, C. Dalla Man, M. Campioni, A. Basu, G. Toffolo, C. Cobelli, and R. A. Rizza Prediction of Postprandial Glycemic Exposure: Utility of fasting and 2-h glucose measurements alone and in combination with assessment of body composition, fitness, and strength Diabetes Care, December 1, 2006; 29(12): 2708 - 2713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Aekplakorn, P. Bunnag, M. Woodward, P. Sritara, S. Cheepudomwit, S. Yamwong, T. Yipintsoi, and R. Rajatanavin A Risk Score for Predicting Incident Diabetes in the Thai Population Diabetes Care, August 1, 2006; 29(8): 1872 - 1877. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Abdul-Ghani, K. Williams, R. DeFronzo, and M. Stern Risk of Progression to Type 2 Diabetes Based on Relationship Between Postload Plasma Glucose and Fasting Plasma Glucose Diabetes Care, July 1, 2006; 29(7): 1613 - 1618. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Brunner, M. J. Shipley, D. R. Witte, J. H. Fuller, and M. G. Marmot Relation Between Blood Glucose and Coronary Mortality Over 33 Years in the Whitehall Study Diabetes Care, January 1, 2006; 29(1): 26 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J.G. Hanley, A. J. Karter, K. Williams, A. Festa, R. B. D'Agostino Jr, L. E. Wagenknecht, and S. M. Haffner Prediction of Type 2 Diabetes Mellitus With Alternative Definitions of the Metabolic Syndrome: The Insulin Resistance Atherosclerosis Study Circulation, December 13, 2005; 112(24): 3713 - 3721. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tirosh, I. Shai, D. Tekes-Manova, E. Israeli, D. Pereg, T. Shochat, I. Kochba, A. Rudich, and the Israeli Diabetes Research Group Normal Fasting Plasma Glucose Levels and Type 2 Diabetes in Young Men N. Engl. J. Med., October 6, 2005; 353(14): 1454 - 1462. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. LaMonte, S. N. Blair, and T. S. Church Physical activity and diabetes prevention J Appl Physiol, September 1, 2005; 99(3): 1205 - 1213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. I. Schmidt, B. B. Duncan, H. Bang, J. S. Pankow, C. M. Ballantyne, S. H. Golden, A. R. Folsom, L. E. Chambless, and for the Atherosclerosis Risk in Communities Invest Identifying Individuals at High Risk for Diabetes: The Atherosclerosis Risk in Communities study Diabetes Care, August 1, 2005; 28(8): 2013 - 2018. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Levantesi, A. Macchia, R. Marfisi, M. G. Franzosi, A. P. Maggioni, G. L. Nicolosi, C. Schweiger, L. Tavazzi, G. Tognoni, F. Valagussa, et al. Metabolic Syndrome and Risk of Cardiovascular Events After Myocardial Infarction J. Am. Coll. Cardiol., July 19, 2005; 46(2): 277 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Sedor and J. R. Schelling Association of Metabolic Syndrome in Nondiabetic Patients with Increased Risk for Chronic Kidney Disease: The Fat Lady Sings J. Am. Soc. Nephrol., July 1, 2005; 16(7): 1880 - 1882. [Full Text] [PDF]
|
|
|
|
|
|
T. J. Orchard, M. Temprosa, R. Goldberg, S. Haffner, R. Ratner, S. Marcovina, S. Fowler, and for the Diabetes Prevention Program Research Group The Effect of Metformin and Intensive Lifestyle Intervention on the Metabolic Syndrome: The Diabetes Prevention Program Randomized Trial Ann Intern Med, April 19, 2005; 142(8): 611 - 619. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Tuomilehto Primary Prevention of Type 2 Diabetes: Lifestyle Intervention Works and Saves Money, but What Should Be Done with Smokers? Ann Intern Med, March 1, 2005; 142(5): 381 - 383. [Full Text] [PDF]
|
|
|
|
|
|
W. Rathmann, S. Martin, B. Haastert, A. Icks, R. Holle, H. Lowel, G. Giani, and for the KORA Study Group Performance of Screening Questionnaires and Risk Scores for Undiagnosed Diabetes: The KORA Survey 2000 Arch Intern Med, February 28, 2005; 165(4): 436 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Kanaya, C. L. W. Fyr, N. de Rekeneire, R. I. Shorr, A. V. Schwartz, B. H. Goodpaster, A. B. Newman, T. Harris, and E. Barrett-Connor Predicting the Development of Diabetes in Older Adults: The derivation and validation of a prediction rule Diabetes Care, February 1, 2005; 28(2): 404 - 408. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
The Diabetes Prevention Program Research Group Strategies to Identify Adults at High Risk for Type 2 Diabetes: The Diabetes Prevention Program Diabetes Care, January 1, 2005; 28(1): 138 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Lyssenko, P. Almgren, D. Anevski, R. Perfekt, K. Lahti, M. Nissen, B. Isomaa, B. Forsen, N. Homstrom, C. Saloranta, et al. Predictors of and Longitudinal Changes in Insulin Sensitivity and Secretion Preceding Onset of Type 2 Diabetes Diabetes, January 1, 2005; 54(1): 166 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Stern, K. Williams, C. Gonzalez-Villalpando, K. J. Hunt, and S. M. Haffner Does the Metabolic Syndrome Improve Identification of Individuals at Risk of Type 2 Diabetes and/or Cardiovascular Disease? Diabetes Care, November 1, 2004; 27(11): 2676 - 2681. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Meigs Metabolic Syndrome: In search of a clinical role Diabetes Care, November 1, 2004; 27(11): 2761 - 2763. [Full Text] [PDF]
|
|
|
|
 |
|
 A. W. Lyon, E. T. Larsen, and A. L. Edwards The impact of new guidelines for glucose tolerance testing on clinical practice and laboratory services Can. Med. Assoc. J., October 26, 2004; 171(9): 1067 - 1069. [Full Text] [PDF]
|
|
|
|
|
|
E. Chiquette, G. Ramirez, and R. DeFronzo A Meta-analysis Comparing the Effect of Thiazolidinediones on Cardiovascular Risk Factors Arch Intern Med, October 25, 2004; 164(19): 2097 - 2104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Nikander, A. Tiitinen, K. Laitinen, M. Tikkanen, and O. Ylikorkala Effects of Isolated Isoflavonoids on Lipids, Lipoproteins, Insulin Sensitivity, and Ghrelin in Postmenopausal Women J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3567 - 3572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Tai, S. Y. Goh, J. J.M. Lee, M.-S. Wong, D. Heng, K. Hughes, S. K. Chew, J. Cutter, W. Chew, K. Gu, et al. Lowering the Criterion for Impaired Fasting Glucose: Impact on disease prevalence and associated risk of diabetes and ischemic heart disease Diabetes Care, July 1, 2004; 27(7): 1728 - 1734. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J.G. Hanley, A. Festa, R. B. D'Agostino, L. E. Wagenknecht, P. J. Savage, R. P. Tracy, M. F. Saad, and S. M. Haffner Metabolic and Inflammation Variable Clusters and Prediction of Type 2 Diabetes: Factor Analysis Using Directly Measured Insulin Sensitivity Diabetes, July 1, 2004; 53(7): 1773 - 1781. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Meigs, K. Williams, L. M. Sullivan, K. J. Hunt, S. M. Haffner, M. P. Stern, C. Gonzalez Villalpando, J. S. Perhanidis, D. M. Nathan, R. B. D'Agostino Jr, et al. Using Metabolic Syndrome Traits for Efficient Detection of Impaired Glucose Tolerance Diabetes Care, June 1, 2004; 27(6): 1417 - 1426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Expert Committee on the Diagnosis and Classificati Follow-up Report on the Diagnosis of Diabetes Mellitus Clin. Diabetes, April 1, 2004; 22(2): 71 - 79. [Full Text] [PDF]
|
|
|
|
|
|
W.E. Feeman Jr, N. Sattar, D. S. J. O'Reilly, C. J. Packard, J. Shepherd, A. Gaw, P. W. Macfarlane, S. M. Cobbe, O. Scherbakova, I. Ford, et al. Metabolic Syndrome and Diabetes Mellitus Circulation, January 27, 2004; 109 (3): e23 - e23. [Full Text] [PDF]
|
|
|
|
|
|
M. J. McNeely and E. J. Boyko Type 2 Diabetes Prevalence in Asian Americans: Results of a national health survey Diabetes Care, January 1, 2004; 27(1): 66 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Follow-up Report on the Diagnosis of Diabetes Mellitus Diabetes Spectr, January 1, 2004; 17(1): 51 - 59. [Full Text] [PDF]
|
|
|
|
|
|
C. Lorenzo, M. Okoloise, K. Williams, M. P. Stern, and S. M. Haffner The Metabolic Syndrome as Predictor of Type 2 Diabetes: The San Antonio Heart Study Diabetes Care, November 1, 2003; 26(11): 3153 - 3159. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
The Expert Committee on the Diagnosis and Classifi Follow-up Report on the Diagnosis of Diabetes Mellitus Diabetes Care, November 1, 2003; 26(11): 3160 - 3167. [Full Text] [PDF]
|
|
|
|
|
|
Z. T. Bloomgarden Prevention of Obesity and Diabetes Diabetes Care, November 1, 2003; 26(11): 3172 - 3178. [Full Text] [PDF]
|
|
|
|
|
|
J. B. Meigs, P. W.F. Wilson, D. M. Nathan, R. B. D'Agostino Sr., K. Williams, and S. M. Haffner Prevalence and Characteristics of the Metabolic Syndrome in the San Antonio Heart and Framingham Offspring Studies Diabetes, August 1, 2003; 52(8): 2160 - 2167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Meigs, D. C. Muller, D. M. Nathan, D. R. Blake, and R. Andres The Natural History of Progression From Normal Glucose Tolerance to Type 2 Diabetes in the Baltimore Longitudinal Study of Aging Diabetes, June 1, 2003; 52(6): 1475 - 1484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. I. Schmidt, B. B. Duncan, A. Vigo, J. Pankow, C. M. Ballantyne, D. Couper, F. Brancati, and A. R. Folsom Detection of Undiagnosed Diabetes and Other Hyperglycemia States: The Atherosclerosis Risk in Communities Study Diabetes Care, May 1, 2003; 26(5): 1338 - 1343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lindstrom and J. Tuomilehto The Diabetes Risk Score: A practical tool to predict type 2 diabetes risk Diabetes Care, March 1, 2003; 26(3): 725 - 731. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. McNeely, E. J. Boyko, D. L. Leonetti, S. E. Kahn, and W. Y. Fujimoto Comparison of a Clinical Model, the Oral Glucose Tolerance Test, and Fasting Glucose for Prediction of Type 2 Diabetes Risk in Japanese Americans Diabetes Care, March 1, 2003; 26(3): 758 - 763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Stern, K. Williams, and S. M. Haffner Do We Need the Oral Glucose Tolerance Test to Identify Future Cases of Type 2 Diabetes? Diabetes Care, March 1, 2003; 26(3): 940 - 941. [Full Text] [PDF]
|
|
|
|
|
|
Z. T. Bloomgarden Cardiovascular Disease and Diabetes Diabetes Care, January 1, 2003; 26(1): 230 - 237. [Full Text] [PDF]
|
|
|
|
|
|
G. Bombassei Optimal Prediction of Diabetes Ann Intern Med, November 19, 2002; 137(10): 856 - 856. [Full Text] [PDF]
|
|
|
|
Article
